These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8540714)

  • 21. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients.
    Traunmüller F; Schenk P; Mittermeyer C; Thalhammer-Scherrer R; Ratheiser K; Thalhammer F
    J Antimicrob Chemother; 2002 Jan; 49(1):129-34. PubMed ID: 11751776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ceftazidime in normal and uremic subjects.
    Leroy A; Leguy F; Borsa F; Spencer GR; Fillastre JP; Humbert G
    Antimicrob Agents Chemother; 1984 May; 25(5):638-42. PubMed ID: 6375562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftazidime in the elderly: appropriateness of twice-daily dosing.
    Sirgo MA; Norris S
    DICP; 1991 Mar; 25(3):284-8. PubMed ID: 2028636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.
    Li X; Qi H; Jin F; Yao BF; Wu YE; Qi YJ; Kou C; Wu XR; Luo XJ; Shen YH; Zheng X; Wang YH; Xu F; Jiao WW; Li JQ; Xiao J; Dong YN; Du B; Shi HY; Xu BP; Shen AD; Zhao W
    Eur J Pharm Sci; 2021 Aug; 163():105868. PubMed ID: 33951483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ceftazidime in premature, newborn and young infants.
    Prinsloo JG; Delport SD; Moncrieff J; Paton AM
    S Afr Med J; 1984 May; 65(20):809-11. PubMed ID: 6374925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration.
    Boccazzi A; Rizzo M; Caccamo ML; Assael BM
    Antimicrob Agents Chemother; 1983 Dec; 24(6):955-6. PubMed ID: 6362562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of ceftazidime in surgical patients with intra-abdominal infection.
    Heim-Duthoy KL; Bubrick MP; Cocchetto DM; Matzke GR
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1845-7. PubMed ID: 3072925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.
    Kemmerich B; Warns H; Lode H; Borner K; Koeppe P; Knothe H
    Antimicrob Agents Chemother; 1983 Sep; 24(3):333-8. PubMed ID: 6357074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of ceftazidime in infections in neonates and premature infants].
    Haruta T; Ohkura K; Kuroki S; Yamamoto H; Yoshioka M; Kobayashi Y
    Jpn J Antibiot; 1986 Aug; 39(8):2163-70. PubMed ID: 3540348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
    Master V; Roberts GW; Coulthard KP; Baghurst PA; Martin A; Roberts ME; Onishko CR; Martin AJ; Linke RJ; Holmes M; Jarvinen A; Kennedy D; Colebatch KA; Hansman D; Parsons DW
    Pediatr Pulmonol; 2001 May; 31(5):367-76. PubMed ID: 11340683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.
    Robaux MA; Dube L; Caillon J; Bugnon D; Kergueris MF; Navas D; Le Conte P; Baron D; Potel G
    J Antimicrob Chemother; 2001 May; 47(5):617-22. PubMed ID: 11328773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ceftazidime in patients with renal insufficiency.
    Welage LS; Schultz RW; Schentag JJ
    Antimicrob Agents Chemother; 1984 Feb; 25(2):201-4. PubMed ID: 6370127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic profiles of ceftazidime in cochlear perilymph, cerebrospinal fluid and plasma: a high-performance liquid chromatographic study.
    Sun AH; Parnes LS; Freeman DJ
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):256-9. PubMed ID: 8587777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.
    Conil JM; Georges B; Lavit M; Seguin T; Tack I; Samii K; Chabanon G; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):529-38. PubMed ID: 17966838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population Pharmacokinetics and Dosing Optimization of Ceftazidime in Infants.
    Shi ZR; Chen XK; Tian LY; Wang YK; Zhang GY; Dong L; Jirasomprasert T; Jacqz-Aigrain E; Zhao W
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
    Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
    Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.